Ratings by H.C. Wainwright (Andrew Fein)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/5/2026 | Amylyx Pharmaceuticals inc. | AMLX | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2026 | Dyne Therapeutics | DYN | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2026 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2026 | Immunic Inc. | IMUX | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2026 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2026 | Palvella Therapeutics | PVLA | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2026 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (Buy) |
|
Details | ||
| 2/23/2026 | Insmed | INSM | Maintain | Buy (Buy) |
|
Details | ||
| 2/17/2026 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2026 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2026 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2026 | Amylyx Pharmaceuticals inc. | AMLX | Maintain | Buy (N/A) |
|
Details | ||
| 2/9/2026 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 1/9/2026 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Buy (N/A) |
|
Details | ||
| 12/18/2025 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 12/18/2025 | DBV Technologies S.A | DBVT | Maintain | Buy (N/A) |
|
Details | ||
| 12/18/2025 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2025 | BioCryst Pharma | BCRX | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2025 | Stoke Therapeutics | STOK | Maintain | Buy (N/A) |
|
Details | ||
| 12/15/2025 | Palvella Therapeutics | PVLA | Maintain | Buy (N/A) |
|
Details | ||
| 12/15/2025 | DBV Technologies S.A | DBVT | Maintain | Buy (N/A) |
|
Details | ||
| 12/11/2025 | Palvella Therapeutics | PVLA | Maintain | Buy (Buy) |
|
Details | ||
| 12/10/2025 | Kymera Therapeutics | KYMR | Maintain | Buy (N/A) |
|
Details | ||
| 12/9/2025 | Terns Pharmaceuticals | TERN | Maintain | Buy (N/A) |
|
Details | ||
| 12/8/2025 | Dyne Therapeutics | DYN | Maintain | Buy (N/A) |
|
Details | ||
| 12/8/2025 | Fulcrum Therapeutics | FULC | Maintain | Buy (N/A) |
|
Details | ||
| 11/24/2025 | Fulcrum Therapeutics | FULC | Maintain | Buy (N/A) |
|
Details | ||
| 11/21/2025 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 11/20/2025 | Protera Therapeutics | TARA | Maintain | Buy (Buy) |
|
Details | ||
| 11/14/2025 | Immunic Inc. | IMUX | Maintain | Buy (N/A) |
|
Details | ||
| 11/12/2025 | Arcturus Therapeutics | ARCT | Maintain | Neutral (N/A) |
|
Details | ||
| 11/12/2025 | Madrigal Pharmaceuticals | MDGL | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2025 | Amylyx Pharmaceuticals inc. | AMLX | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2025 | Prothena Corp | PRTA | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2025 | Palvella Therapeutics | PVLA | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2025 | Dyne Therapeutics | DYN | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2025 | Kymera Therapeutics | KYMR | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2025 | Terns Pharmaceuticals | TERN | Upgrade | Buy (Neutral) |
14.03 (42.82) |
205.2% | Details | |
| 10/31/2025 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2025 | DBV Technologies S.A | DBVT | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2025 | DBV Technologies S.A | DBVT | Maintain | Buy (N/A) |
|
Details | ||
| 10/27/2025 | I-Mab | IMAB | Maintain | Buy (Buy) |
|
Details | ||
| 10/24/2025 | Arcturus Therapeutics | ARCT | Downgrade | Neutral (Buy) |
12.00 (7.11) |
-40.75% | Details | |
| 10/23/2025 | Terns Pharmaceuticals | TERN | Maintain | Neutral (Neutral) |
|
Details | ||
| 10/23/2025 | Alector Inc. | ALEC | Maintain | Buy (N/A) |
|
Details | ||
| 10/20/2025 | Fulcrum Therapeutics | FULC | Maintain | Buy (Buy) |
|
Details | ||
| 10/15/2025 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (Buy) |
|
Details | ||
| 10/15/2025 | BioCryst Pharma | BCRX | Maintain | Buy (Buy) |
|
Details | ||
| 10/10/2025 | Akero Therapeutics | AKRO | Downgrade | Neutral (Buy) |
54.08 (54.74) |
1.22% | Details | |
| 10/9/2025 | Protera Therapeutics | TARA | Maintain | Buy (Buy) |
|
Details | ||
| 10/8/2025 | Prothena Corp | PRTA | Maintain | Buy (N/A) |
|
Details | ||
| 10/6/2025 | Protera Therapeutics | TARA | Maintain | Buy (Buy) |
|
Details | ||
| 9/29/2025 | United Therapeutics Corp. | UTHR | Maintain | Buy (Buy) |
|
Details | ||
| 9/26/2025 | Palvella Therapeutics | PVLA | Maintain | Buy (N/A) |
|
Details | ||
| 9/24/2025 | Alector Inc. | ALEC | Maintain | Buy (Buy) |
|
Details | ||
| 9/19/2025 | Arvinas Inc. | ARVN | Maintain | Buy (Buy) |
|
Details | ||
| 9/19/2025 | Palvella Therapeutics | PVLA | Maintain | Buy (Buy) |
|
Details | ||
| 9/19/2025 | Kymera Therapeutics | KYMR | Maintain | Buy (N/A) |
|
Details | ||
| 9/19/2025 | 89bio Inc. | ETNB | Downgrade | Neutral (Buy) |
14.96 (14.84) |
-0.8% | Details | |
| 9/5/2025 | Biogen | BIIB | Maintain | Buy (Buy) |
|
Details | ||
| 9/5/2025 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 9/4/2025 | Terns Pharmaceuticals | TERN | New Coverage | Neutral (N/A) |
7.45 (14.03) |
88.32% | Details | |
| 9/4/2025 | MetaVia | MTVA | New Coverage | Buy (N/A) |
0.67 (1.55) |
131.34% | Details | |
| 9/4/2025 | Madrigal Pharmaceuticals | MDGL | New Coverage | Buy (N/A) |
435.27 (432.83) |
-0.56% | Details | |
| 9/4/2025 | Arcturus Therapeutics | ARCT | New Coverage | Buy (N/A) |
17.19 (12.00) |
-30.19% | Details | |
| 9/4/2025 | Akero Therapeutics | AKRO | New Coverage | Buy (N/A) |
45.63 (54.08) |
18.52% | Details | |
| 9/4/2025 | 89bio Inc. | ETNB | New Coverage | Buy (N/A) |
9.24 (14.96) |
61.9% | Details | |
| 8/21/2025 | I-Mab | IMAB | Maintain | Buy (Buy) |
|
Details | ||
| 8/18/2025 | Palvella Therapeutics | PVLA | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2025 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2025 | Immunic Inc. | IMUX | Maintain | Buy (Buy) |
|
Details | ||
| 8/8/2025 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2025 | Keros Therapeutics | KROS | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2025 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/1/2025 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2025 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 7/29/2025 | Fulcrum Therapeutics | FULC | Upgrade | Buy (Neutral) |
7.81 (8.17) |
4.61% | Details | |
| 7/14/2025 | Stoke Therapeutics | STOK | Maintain | Buy (Buy) |
|
Details | ||
| 7/11/2025 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Buy (Buy) |
|
Details | ||
| 7/8/2025 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Buy (N/A) |
|
Details | ||
| 6/27/2025 | I-Mab | IMAB | Maintain | Buy (Buy) |
|
Details | ||
| 6/26/2025 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2025 | Kymera Therapeutics | KYMR | Maintain | Buy (N/A) |
|
Details | ||
| 6/24/2025 | I-Mab | IMAB | Maintain | Buy (Buy) |
|
Details | ||
| 6/23/2025 | Vertex | VRTX | Maintain | Buy (Buy) |
|
Details | ||
| 6/18/2025 | Dyne Therapeutics | DYN | Maintain | Buy (Buy) |
|
Details | ||
| 6/12/2025 | Biogen | BIIB | Maintain | Buy (Buy) |
|
Details | ||
| 6/11/2025 | Amylyx Pharmaceuticals inc. | AMLX | Maintain | Buy (Buy) |
|
Details | ||
| 6/11/2025 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 6/3/2025 | Arvinas Inc. | ARVN | Maintain | Buy (Buy) |
|
Details | ||
| 6/3/2025 | Kymera Therapeutics | KYMR | Maintain | Buy (Buy) |
|
Details | ||
| 6/2/2025 | Zentalis Pharmaceuticals | ZNTL | Maintain | Buy (Buy) |
|
Details | ||
| 5/27/2025 | Vigil Neuroscience Inc | VIGL | Downgrade | Neutral (Buy) |
7.89 (8.05) |
2.03% | Details | |
| 5/27/2025 | Merus N.V. | MRUS | Maintain | Buy (Buy) |
|
Details | ||
| 5/27/2025 | Prothena Corp | PRTA | Maintain | Buy (N/A) |
|
Details | ||
| 5/27/2025 | Unity Biotechnology Inc | UBX | Downgrade | Neutral (Buy) |
0.78 (0.20) |
-74.36% | Details | |
| 5/15/2025 | Stoke Therapeutics | STOK | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2025 | Annexon Biosciences | ANNX | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2025 | Alector Inc. | ALEC | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2025 | Prothena Corp | PRTA | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2025 | Amylyx Pharmaceuticals inc. | AMLX | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2025 | Dyne Therapeutics | DYN | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2025 | Keros Therapeutics | KROS | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2025 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2025 | Vertex | VRTX | Maintain | Buy (Buy) |
|
Details | ||
| 5/5/2025 | DBV Technologies S.A | DBVT | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2025 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2025 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 5/1/2025 | AC Immune SA | ACIU | Maintain | Buy (N/A) |
|
Details | ||
| 4/23/2025 | Unity Biotechnology Inc | UBX | Maintain | Buy (Buy) |
|
Details | ||
| 4/22/2025 | Insmed | INSM | Maintain | Buy (Buy) |
|
Details | ||
| 4/22/2025 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 4/8/2025 | Arvinas Inc. | ARVN | Maintain | Buy (Buy) |
|
Details | ||
| 4/4/2025 | I-Mab | IMAB | Maintain | Buy (N/A) |
|
Details | ||
| 3/27/2025 | Zentalis Pharmaceuticals | ZNTL | Maintain | Buy (Buy) |
|
Details | ||
| 3/25/2025 | Unity Biotechnology Inc | UBX | Maintain | Buy (N/A) |
|
Details | ||
| 3/20/2025 | Stoke Therapeutics | STOK | Maintain | Buy (Buy) |
|
Details | ||
| 3/19/2025 | Insmed | INSM | Maintain | Buy (Buy) |
|
Details | ||
| 3/17/2025 | Dyne Therapeutics | DYN | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2025 | Sutro Biopharma | STRO | Downgrade | Neutral (Buy) |
0.81 (25.29) |
3022.22% | Details | |
| 3/17/2025 | Zentalis Pharmaceuticals | ZNTL | Maintain | Buy (Buy) |
|
Details | ||
| 3/17/2025 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Buy (Buy) |
|
Details | ||
| 3/17/2025 | Vigil Neuroscience Inc | VIGL | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2025 | ProQR Therapeutics N.V. | PRQR | Maintain | Buy (N/A) |
|
Details | ||
| 3/12/2025 | Arvinas Inc. | ARVN | Maintain | Buy (Buy) |
|
Details | ||
| 3/7/2025 | Foghorn Therapeutics | FHTX | Maintain | Buy (Buy) |
|
Details | ||
| 3/6/2025 | Protera Therapeutics | TARA | Maintain | Buy (Buy) |
|
Details | ||
| 3/5/2025 | Annexon Biosciences | ANNX | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2025 | Merus N.V. | MRUS | Maintain | Buy (Buy) |
|
Details | ||
| 2/28/2025 | Dyne Therapeutics | DYN | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2025 | Kymera Therapeutics | KYMR | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2025 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (N/A) |
|
Details | ||
| 2/27/2025 | Keros Therapeutics | KROS | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2025 | BioCryst Pharma | BCRX | Maintain | Buy (Buy) |
|
Details | ||
| 2/21/2025 | Immunic Inc. | IMUX | Maintain | Buy (Buy) |
|
Details | ||
| 2/18/2025 | Stoke Therapeutics | STOK | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2025 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2025 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 2/11/2025 | Palvella Therapeutics | PVLA | Maintain | Buy (Buy) |
|
Details | ||
| 2/10/2025 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 2/3/2025 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 1/30/2025 | Zentalis Pharmaceuticals | ZNTL | Maintain | Buy (N/A) |
|
Details | ||
| 1/7/2025 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (N/A) |
|
Details | ||
| 1/3/2025 | Palvella Therapeutics | PVLA | Maintain | Buy (Buy) |
|
Details | ||
| 12/24/2024 | Palvella Therapeutics | PVLA | New Coverage | Buy (N/A) |
11.80 (134.39) |
1038.9% | Details | |
| 12/20/2024 | Prothena Corp | PRTA | Maintain | Buy (N/A) |
|
Details | ||
| 12/20/2024 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 12/17/2024 | Annexon Biosciences | ANNX | Maintain | Buy (Buy) |
|
Details | ||
| 12/17/2024 | Foghorn Therapeutics | FHTX | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2024 | Neurocrine Bio. | NBIX | Maintain | Buy (Buy) |
|
Details | ||
| 12/13/2024 | Keros Therapeutics | KROS | Maintain | Buy (N/A) |
|
Details | ||
| 12/12/2024 | ProQR Therapeutics N.V. | PRQR | Maintain | Buy (Buy) |
|
Details | ||
| 12/6/2024 | Protera Therapeutics | TARA | Maintain | Buy (Buy) |
|
Details | ||
| 12/6/2024 | Amylyx Pharmaceuticals inc. | AMLX | Maintain | Buy (Buy) |
|
Details | ||
| 12/6/2024 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Buy (Buy) |
|
Details | ||
| 12/2/2024 | Merus N.V. | MRUS | Maintain | Buy (Buy) |
|
Details | ||
| 11/26/2024 | Alector Inc. | ALEC | Maintain | Buy (N/A) |
|
Details | ||
| 11/25/2024 | Immunic Inc. | IMUX | New Coverage | Buy (N/A) |
1.10 (1.23) |
11.82% | Details | |
| 11/13/2024 | Syros Pharmaceuticals | SYRS | Downgrade | Neutral (Buy) |
2.73 (0.12) |
-95.6% | Details | |
| 11/8/2024 | ProQR Therapeutics N.V. | PRQR | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2024 | Amylyx Pharmaceuticals inc. | AMLX | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2024 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 10/24/2024 | DBV Technologies S.A | DBVT | Maintain | Buy (N/A) |
|
Details | ||
| 10/21/2024 | Vertex | VRTX | Maintain | Buy (Buy) |
|
Details | ||
| 10/18/2024 | Amylyx Pharmaceuticals inc. | AMLX | Maintain | Buy (Buy) |
|
Details | ||
| 10/11/2024 | Sutro Biopharma | STRO | Maintain | Buy (Buy) |
|
Details | ||
| 10/7/2024 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Buy (Buy) |
|
Details | ||
| 10/1/2024 | Prothena Corp | PRTA | Maintain | Buy (Buy) |
|
Details | ||
| 9/18/2024 | AC Immune SA | ACIU | Maintain | Buy (Buy) |
|
Details | ||
| 9/13/2024 | Fulcrum Therapeutics | FULC | Downgrade | Neutral (Buy) |
3.44 (7.81) |
127.03% | Details | |
| 9/6/2024 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Buy (Buy) |
|
Details | ||
| 8/29/2024 | Neurocrine Bio. | NBIX | Maintain | Buy (Buy) |
|
Details | ||
| 8/29/2024 | Insmed | INSM | Maintain | Buy (Buy) |
|
Details | ||
| 8/13/2024 | Dyne Therapeutics | DYN | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2024 | Annexon Biosciences | ANNX | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2024 | Syros Pharmaceuticals | SYRS | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2024 | Kymera Therapeutics | KYMR | Maintain | Buy (N/A) |
|
Details | ||
| 8/2/2024 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (N/A) |
|
Details | ||
| 8/2/2024 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 8/2/2024 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 7/25/2024 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 7/19/2024 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 7/19/2024 | Vigil Neuroscience Inc | VIGL | Maintain | Buy (N/A) |
|
Details | ||
| 7/15/2024 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Buy (Buy) |
|
Details | ||
| 7/11/2024 | Amylyx Pharmaceuticals inc. | AMLX | Maintain | Buy (Buy) |
|
Details | ||
| 7/8/2024 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 7/2/2024 | Insmed | INSM | Maintain | Buy (Buy) |
|
Details | ||
| 6/28/2024 | Vigil Neuroscience Inc | VIGL | Maintain | Buy (Buy) |
|
Details | ||
| 6/26/2024 | Syros Pharmaceuticals | SYRS | Maintain | Buy (Buy) |
|
Details | ||
| 6/24/2024 | Amylyx Pharmaceuticals inc. | AMLX | Maintain | Buy (Buy) |
|
Details | ||
| 6/18/2024 | Zentalis Pharmaceuticals | ZNTL | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2024 | Kymera Therapeutics | KYMR | Maintain | Buy (Buy) |
|
Details | ||
| 5/29/2024 | Merus N.V. | MRUS | Maintain | Buy (N/A) |
|
Details | ||
| 5/29/2024 | Insmed | INSM | Maintain | Buy (N/A) |
|
Details | ||
| 5/20/2024 | Dyne Therapeutics | DYN | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2024 | Alector Inc. | ALEC | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2024 | Prothena Corp | PRTA | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2024 | DBV Technologies S.A | DBVT | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2024 | Zentalis Pharmaceuticals | ZNTL | Maintain | Buy (N/A) |
|
Details | ||
| 5/3/2024 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 5/3/2024 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Buy (N/A) |
|
Details | ||
| 5/2/2024 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 4/25/2024 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 4/16/2024 | Unity Biotechnology Inc | UBX | Maintain | Buy (N/A) |
|
Details | ||
| 4/15/2024 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 4/12/2024 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 3/26/2024 | Sutro Biopharma | STRO | Maintain | Buy (N/A) |
|
Details | ||
| 3/18/2024 | I-Mab | IMAB | Maintain | Buy (N/A) |
|
Details | ||
| 3/12/2024 | Amylyx Pharmaceuticals inc. | AMLX | Maintain | Buy (N/A) |
|
Details | ||
| 2/29/2024 | Merus N.V. | MRUS | Maintain | Buy (N/A) |
|
Details | ||
| 2/29/2024 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2024 | Fulcrum Therapeutics | FULC | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2024 | Kymera Therapeutics | KYMR | Maintain | Buy (N/A) |
|
Details | ||
| 2/20/2024 | Dyne Therapeutics | DYN | New Coverage | Buy (N/A) |
22.91 (14.86) |
-35.14% | Details | |
| 2/16/2024 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 2/14/2024 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Buy (N/A) |
|
Details | ||
| 2/6/2024 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 12/11/2023 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2023 | Amylyx Pharmaceuticals inc. | AMLX | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2023 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2023 | Zentalis Pharmaceuticals | ZNTL | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2023 | Kymera Therapeutics | KYMR | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2023 | C4 Therapeutics | CCCC | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2023 | Deciphera | DCPH | Maintain | Buy (N/A) |
|
Details | ||
| 10/6/2023 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 8/23/2023 | Fulcrum Therapeutics | FULC | Upgrade | Buy (Neutral) |
5.43 (8.17) |
50.46% | Details | |
| 8/21/2023 | I-Mab | IMAB | Maintain | Buy (N/A) |
|
Details | ||
| 8/21/2023 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 6/6/2023 | Bellerophon Therapeutics | BLPH | Maintain | Buy (N/A) |
|
Details | ||
| 5/23/2023 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2023 | Fulcrum Therapeutics | FULC | Maintain | Neutral (N/A) |
|
Details | ||
| 5/9/2023 | Foghorn Therapeutics | FHTX | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2023 | C4 Therapeutics | CCCC | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2023 | Merus N.V. | MRUS | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2023 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2023 | Prothena Corp | PRTA | Maintain | Buy (N/A) |
|
Details | ||
| 5/2/2023 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 4/3/2023 | I-Mab | IMAB | Maintain | Buy (N/A) |
|
Details | ||
| 3/31/2023 | Sutro Biopharma | STRO | Maintain | Buy (N/A) |
|
Details | ||
| 3/30/2023 | ProQR Therapeutics N.V. | PRQR | Maintain | Buy (N/A) |
|
Details | ||
| 3/10/2023 | Fulcrum Therapeutics | FULC | Downgrade | Neutral (Buy) |
4.82 (8.17) |
69.5% | Details | |
| 3/1/2023 | Merus N.V. | MRUS | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2023 | MEI Pharma | MEIP | Maintain | Buy (N/A) |
|
Details | ||
| 2/8/2023 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2022 | Unity Biotechnology Inc | UBX | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2022 | Sutro Biopharma | STRO | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2022 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2022 | Blueprint Medicines | BPMC | Maintain | Buy (N/A) |
|
Details | ||
| 10/26/2022 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 10/24/2022 | Amylyx Pharmaceuticals inc. | AMLX | Maintain | Buy (N/A) |
|
Details | ||
| 10/6/2022 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Buy (N/A) |
|
Details | ||
| 8/29/2022 | Vigil Neuroscience Inc | VIGL | New Coverage | Buy (N/A) |
8.38 (8.05) |
-3.94% | Details | |
| 8/5/2022 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2022 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2022 | Deciphera | DCPH | Maintain | Buy (N/A) |
|
Details | ||
| 7/27/2022 | Seagen | SGEN | Maintain | Buy (N/A) |
|
Details | ||
| 5/31/2022 | I-Mab | IMAB | Maintain | Buy (N/A) |
|
Details | ||
| 5/24/2022 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 5/17/2022 | Syros Pharmaceuticals | SYRS | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2022 | Epizyme | EPZM | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2022 | Protera Therapeutics | TARA | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2022 | Eloxx Pharma | ELOX | Maintain | Neutral (N/A) |
|
Details | ||
| 5/9/2022 | C4 Therapeutics | CCCC | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2022 | Amarin Corporation | AMRN | Downgrade | Neutral (Buy) |
1.56 (14.06) |
801.28% | Details | |
| 3/16/2022 | Aprea | APRE | Maintain | Neutral (N/A) |
|
Details | ||
| 3/9/2022 | Cortexyme Inc. | CRTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2022 | Seagen | SGEN | Maintain | Buy (N/A) |
|
Details | ||
| 2/1/2022 | Amylyx Pharmaceuticals inc. | AMLX | New Coverage | Buy (N/A) |
23.18 (13.85) |
-40.25% | Details | |
| 1/18/2022 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 12/21/2021 | DBV Technologies S.A | DBVT | Maintain | Buy (N/A) |
|
Details | ||
| 12/1/2021 | Deciphera | DCPH | Maintain | Buy (N/A) |
|
Details | ||
| 11/22/2021 | Foghorn Therapeutics | FHTX | New Coverage | Buy (N/A) |
13.68 (5.78) |
-57.75% | Details | |
| 9/1/2021 | I-Mab | IMAB | Maintain | Buy (N/A) |
|
Details | ||
| 8/16/2021 | Aprea | APRE | Maintain | Neutral (N/A) |
|
Details | ||
| 8/4/2021 | Deciphera | DCPH | Maintain | Buy (N/A) |
|
Details | ||
| 7/26/2021 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (N/A) |
|
Details | ||
| 6/18/2021 | Sutro Biopharma | STRO | New Coverage | Buy (N/A) |
18.73 (0.81) |
-95.68% | Details | |
| 6/10/2021 | Prothena Corp | PRTA | Maintain | Buy (N/A) |
|
Details | ||
| 6/7/2021 | Unity Biotechnology Inc | UBX | New Coverage | Buy (N/A) |
4.56 (0.78) |
-82.89% | Details | |
| 6/4/2021 | Protera Therapeutics | TARA | New Coverage | Buy (N/A) |
9.26 (5.90) |
-36.29% | Details | |
| 6/4/2021 | C4 Therapeutics | CCCC | New Coverage | Buy (N/A) |
38.15 (3.04) |
-92.03% | Details | |
| 5/6/2021 | United Therapeutics Corp. | UTHR | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2021 | Deciphera | DCPH | Maintain | Buy (N/A) |
|
Details | ||
| 4/13/2021 | Pulmatrix | PULM | Maintain | Buy (N/A) |
|
Details | ||
| 3/30/2021 | Matinas BioPharma Holdings Inc. | MTNB | Maintain | Buy (N/A) |
|
Details | ||
| 3/18/2021 | Translate Bio | TBIO | Maintain | Buy (N/A) |
|
Details | ||
| 3/3/2021 | I-Mab | IMAB | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2021 | Kalvista Pharmaceuticals Inc | KALV | Maintain | Buy (N/A) |
|
Details | ||
| 2/2/2021 | Concert Pharmaceuticals | CNCE | Maintain | Buy (N/A) |
|
Details | ||
| 2/2/2021 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/1/2021 | United Therapeutics Corp. | UTHR | Upgrade | Buy (Neutral) |
163.82 (478.16) |
191.88% | Details | |
| 12/14/2020 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 12/7/2020 | Prothena Corp | PRTA | New Coverage | Buy (N/A) |
11.53 (9.59) |
-16.83% | Details | |
| 12/7/2020 | I-Mab | IMAB | New Coverage | Buy (N/A) |
37.99 (4.63) |
-87.81% | Details | |
| 11/6/2020 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2020 | Syros Pharmaceuticals | SYRS | Upgrade | Buy (Neutral) |
7.58 (0.12) |
-98.42% | Details | |
| 8/20/2020 | Denali Therapeutics Inc. | DNLI | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2020 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2020 | Seattle Genetics | SGEN | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2020 | Vertex | VRTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2020 | BELLUS Health Inc. | BLU | New Coverage | Buy (N/A) |
9.62 (14.74) |
53.22% | Details | |
| 6/26/2020 | Merus N.V. | MRUS | New Coverage | Buy (N/A) |
15.80 (90.00) |
469.62% | Details | |
| 6/25/2020 | United Therapeutics Corp. | UTHR | Maintain | Neutral (N/A) |
|
Details | ||
| 6/24/2020 | Alector Inc. | ALEC | New Coverage | Buy (N/A) |
31.02 (2.00) |
-93.55% | Details | |
| 6/24/2020 | Cortexyme Inc. | CRTX | New Coverage | Buy (N/A) |
49.26 (1.95) |
-96.04% | Details | |
| 6/22/2020 | Aprea | APRE | New Coverage | Neutral (N/A) |
37.90 (0.68) |
-98.21% | Details | |
| 6/17/2020 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 6/15/2020 | Kalvista Pharmaceuticals Inc | KALV | New Coverage | Buy (N/A) |
10.41 (16.23) |
55.91% | Details | |
| 5/4/2020 | Keros Therapeutics | KROS | New Coverage | Buy (N/A) |
28.80 (11.30) |
-60.76% | Details | |
| 4/29/2020 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 3/11/2020 | Sunesis Pharmaceuticals Inc. | SNSS | Maintain | Neutral (N/A) |
|
Details | ||
| 3/6/2020 | Eloxx Pharma | ELOX | Maintain | Neutral (N/A) |
|
Details | ||
| 3/6/2020 | Fulcrrum Therapeutics | FULC | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2020 | Syros Pharmaceuticals | SYRS | Maintain | Neutral (N/A) |
|
Details | ||
| 2/25/2020 | Epizyme | EPZM | Maintain | Buy (N/A) |
|
Details | ||
| 2/19/2020 | Bellerophon Therapeutics | BLPH | Maintain | Buy (N/A) |
|
Details | ||
| 2/18/2020 | Acasti Pharma | ACST | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2020 | Seattle Genetics | SGEN | Maintain | Buy (N/A) |
|
Details | ||
| 12/19/2019 | Aimmune Therapeutics | AIMT | New Coverage | Neutral (N/A) |
31.61 (34.49) |
9.11% | Details | |
| 12/19/2019 | Arvinas Inc. | ARVN | New Coverage | Buy (N/A) |
40.84 (13.60) |
-66.7% | Details | |
| 12/10/2019 | AC Immune SA | ACIU | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2019 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 11/13/2019 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2019 | Seattle Genetics | SGEN | Maintain | Buy (Buy) |
|
Details | ||
| 10/23/2019 | Biogen | BIIB | Maintain | Buy (N/A) |
|
Details | ||
| 10/22/2019 | Seattle Genetics | SGEN | Maintain | Buy (N/A) |
|
Details | ||
| 10/3/2019 | Concert Pharmaceuticals | CNCE | Maintain | Buy (N/A) |
|
Details | ||
| 10/3/2019 | PhaseBio Pharmaceuticals Inc. | PHAS | New Coverage | Buy (N/A) |
4.03 (0.07) |
-98.26% | Details | |
| 10/3/2019 | Deciphera | DCPH | New Coverage | Buy (N/A) |
34.15 (25.59) |
-25.07% | Details | |
| 10/3/2019 | Fulcrrum Therapeutics | FULC | New Coverage | Buy (N/A) |
6.59 (8.17) |
23.98% | Details | |
| 10/3/2019 | Blueprint Medicines | BPMC | New Coverage | Buy (N/A) |
72.92 (129.46) |
77.54% | Details | |
| 7/3/2019 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2019 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2019 | Denali Therapeutics Inc. | DNLI | New Coverage | Buy (N/A) |
19.63 (19.69) |
0.31% | Details | |
| 6/26/2019 | Acasti Pharma | ACST | New Coverage | Buy (N/A) |
1.05 (3.37) |
220.95% | Details | |
| 6/26/2019 | Matinas BioPharma Holdings Inc. | MTNB | New Coverage | Buy (N/A) |
0.81 (0.60) |
-25.93% | Details | |
| 6/26/2019 | Rubius | RUBY | New Coverage | Buy (N/A) |
13.71 (0.08) |
-99.42% | Details | |
| 4/16/2019 | Pulmatrix | PULM | Maintain | Buy (N/A) |
|
Details | ||
| 4/1/2019 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 3/25/2019 | Biogen | BIIB | Maintain | Buy (Buy) |
|
Details | ||
| 3/19/2019 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 12/26/2018 | Corbus Pharmaceuticals | CRBP | New Coverage | Buy (N/A) |
5.28 (8.01) |
51.7% | Details | |
| 12/26/2018 | Neurometrix Inc. | NURO | New Coverage | Buy (N/A) |
0.70 (4.58) |
554.29% | Details | |
| 12/24/2018 | Translate Bio | TBIO | New Coverage | Buy (N/A) |
7.37 (3.23) |
-56.17% | Details | |
| 12/24/2018 | Eloxx Pharma | ELOX | New Coverage | Neutral (N/A) |
12.89 (0.00) |
-100% | Details | |
| 12/20/2018 | AnaptysBio | ANAB | New Coverage | Buy (N/A) |
62.21 (55.41) |
-10.93% | Details | |
| 12/20/2018 | Unum Therapeutics | UMRX | New Coverage | Buy (N/A) |
4.74 (2.35) |
-50.42% | Details | |
| 12/20/2018 | Sunesis Pharmaceuticals Inc. | SNSS | New Coverage | Neutral (N/A) |
0.30 (5.32) |
1673.33% | Details | |
| 12/20/2018 | MEI Pharma | MEIP | New Coverage | Buy (N/A) |
2.16 (3.07) |
42.13% | Details | |
| 12/20/2018 | Constellation Pharmaceuticals | CNST | New Coverage | Buy (N/A) |
5.90 (33.99) |
476.1% | Details | |
| 12/13/2018 | Neurocrine Bio. | NBIX | Maintain | Buy (N/A) |
|
Details | ||
| 11/12/2018 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 10/26/2018 | Vertex | VRTX | Upgrade | Buy (Neutral) |
163.09 (456.69) |
180.02% | Details | |
| 9/25/2018 | Amarin Corporation | AMRN | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2018 | BioCryst Pharma | BCRX | Maintain | Buy (N/A) |
|
Details |
